Vioxx Research - Osteoarthritis, Side-effects, Trials, Stroke, Heart Attack

Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.


Vioxx Research Today

Home

View Latest Issue

Information About Vioxx

Books on Vioxx

Advertising in Research Today

View Other Research Today Publications



Volume 3 (2006), Issue 11 (November)

  1. Impact of Rofecoxib Withdrawal on Cyclooxygenase-2 Utilization among Patients with and without Cardiovascular Risk.
    Value Health, 9(6): 361-8. [Abstract] [Full-text]
  2. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis?
    J Bone Joint Surg Am, 88: 140-7. [Abstract] [Full-text]
  3. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Aliment Pharmacol Ther, 24(10): 1431-8. [Abstract] [Full-text]
  4. Pain after elective arthroscopy of the knee: a prospective, randomised, study comparing conventional NSAID to coxib.
    Knee Surg Sports Traumatol Arthrosc, 14(11): 1166-70. [Abstract] [Full-text]
  5. Nephrotoxicity with cyclooxygenase 2 inhibitor use in children.
    Pediatr Nephrol, 21(12): 1893-7. [Abstract] [Full-text]
  6. Effects of non-steroidal anti-inflammatory drugs on cell proliferation and death in cultured epiphyseal-articular chondrocytes of fetal rats.
    Toxicology, 228(2): 111-23. [Abstract] [Full-text]
  7. Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegeneration.
    J Pharmacol Exp Ther, 319(3): 1219-24. [Abstract] [Full-text]
  8. Use and perceived benefits of handheld computer-based clinical references.
    J Am Med Inform Assoc, 13(6): 619-26. [Abstract] [Full-text]
  9. Prophylactic COX 2 Inhibitor: An End to the Yom Kippur Headache.
    Headache, 46(10): 1487-91. [Abstract] [Full-text]
  10. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.
    Gut, 55(12): 1731-8. [Abstract] [Full-text]
  11. Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions.
    Drug Metab Dispos, 34(12): 2091-6. [Abstract] [Full-text]
  12. The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy.
    Pharmacoepidemiol Drug Saf, 15(12): 852-60. [Abstract] [Full-text]
  13. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
    Pharmacoepidemiol Drug Saf, 15(12): 861-72. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2014 Vioxx Research Today. All Rights Reserved.



Vioxx Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 10 (2013)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 11 (2014)
  Issue 1 (January)
  Issue 2 (February)



Vioxx Books

Fast Facts: Osteoarthritis

Fast Facts: Osteoarthritis